Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now later-stage tilt small index

Urinary Incontinence, Urge: later-stage trial registry

3 of 11 indexed Urinary Incontinence, Urge trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #1,577 of 28,707 conditions by registered trial count.

11 US clinical trials · 3 currently recruiting · #1,577 of 28,707 conditions by registered trial count

Urinary Incontinence, Urge: 11 US clinical trials tracked, 3 recruiting.

Urinary Incontinence, Urge is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is FemmePharma Global Healthcare, running 1 of these trials.

Enrollment posture brief

Registry condition urinary-incontinence-urge

OPEN 3 | RECR 27% | LATE 3 | EARLY 1 | RANK #1577 | SPON 1

Nearest open-share peer: Atherosclerotic Cardiovascular Disease (27% recruiting · 22 trials)

Acute Pancreatitis81.8%Acute Stroke45.5%Acquired Brain Injury36.4%Urinary Incontinence, Ur (th…27%Acute Lung Injury9.1%
Open-enrollment share among volume-matched conditions near Urinary Incontinence, Urge

Urinary Incontinence, Urge lists 3 open slots (27% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Urinary Incontinence, Urge on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Urinary Incontinence, Urge is recruiting below its size-band peers.

    3 of 11 indexed trials (27.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Urinary Incontinence, Urge trials is spread across many organizations.

    FemmePharma Global Healthcare accounts for 1 of 11 trials (9.1%). 11 distinct sponsors appear on at least one study for this condition label.

  3. Typical Urinary Incontinence, Urge enrolment sits around 116 participants.

    Median target enrolment is 116 among the 10 trials that report a genuine target (sentinel values excluded). 4 of those (40%) plan for fewer than 100 participants.

  4. Urinary Incontinence, Urge research is mostly interventional.

    9 interventional and 2 observational studies make up this index (81.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21Phase 43

Open and recent trials

11 total, page 1 of 1

RECRUITING Phase 4 270 participants

TReating Incontinence for Underlying Mental and Physical Health

University of California, San Francisco

NCT05362292

RECRUITING 180 participants

NXT Post-Market Clinical Follow-up

Laborie Medical Technologies

NCT06336304

RECRUITING NA 10 participants

rTMS in Overactive Bladder

The Methodist Hospital Research Institute

NCT06198439

ACTIVE NOT RECRUITING NA 375 participants

Mobility and Voiding Exercises in Older Women With Urinary Incontinence (MoVEonUp)

University of Pennsylvania

NCT05375344

ACTIVE NOT RECRUITING NA 208 participants

INTIBIA Pivotal Study

Coloplast A/S

NCT05250908

COMPLETED Phase 4 116 participants

Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial

University of California, Irvine

NCT05308979

COMPLETED Phase 4 100 participants

Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection

The Cleveland Clinic

NCT05719285

COMPLETED NA 90 participants

Efficacy of Animated Videos to Foster Healthy Bladder Behaviors in Community Women

Kathleen O'Connell

NCT06921915

COMPLETED Phase 2 45 participants

A Study of Oxybutynin for the Treatment of Urge Urinary Incontinence

FemmePharma Global Healthcare

NCT00749632

COMPLETED 32 participants

Bladder Antimuscarinic Medication and Accidental Bowel Leakage

University of Alabama at Birmingham

NCT03543566

COMPLETED NA

Mindfulness-Based Stress Reduction Techniques and Yoga for Treatment of Urinary Urge Incontinence (MBSR-Yoga)

University of Utah

NCT01470560

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 4 3

Named interventions

Most-linked intervention names on Urinary Incontinence, Urge records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Sham Yoga Group Behavioral
1 trials
oxybutynin Drug
1 trials
Multi-Dose Antibiotic Drug
1 trials
Single-Dose Antibiotic Drug
1 trials
eLearning Other
1 trials
INTIBIA Non-Therapeutic Device
1 trials
INTIBIA Therapeutic Device
1 trials
Tolterodine Tartrate ER Drug
1 trials

US sites by state

Facility locations filed on Urinary Incontinence, Urge trials. A trial with sites in several states counts in each.

Ohio 3 trials
California 3 trials
Texas 2 trials
Pennsylvania 2 trials
New Jersey 2 trials
Maryland 2 trials
Virginia 1 trials
Utah 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Urinary Incontinence, Urge page

11 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Urinary Incontinence, Urge condition card totals 11 registered trials; most-linked intervention Sham Yoga Group; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.